What You Cannot Take With Famotidine: Drugs to Avoid

Famotidine is one of the milder drugs in terms of liver-based interactions, but it still interferes with a meaningful list of medications through a different route: by raising stomach pH. Many drugs need an acidic stomach to dissolve properly, and famotidine’s job is to suppress acid production. That tension creates real problems with certain antifungals, cancer drugs, HIV medications, and some antibiotics, among others. The good news is that most of these interactions can be managed with careful timing, but some combinations genuinely need to be avoided.

Why Stomach Acid Matters for Drug Absorption

Famotidine works by blocking histamine H2 receptors in the stomach lining, which reduces the amount of acid your stomach produces. For heartburn and ulcer treatment, that is the whole point. But plenty of oral medications were designed to dissolve in an acidic environment. When famotidine raises your stomach’s pH, these drugs do not break down as well, which means less of the active ingredient reaches your bloodstream. The technical term for this is pH-dependent solubility, and it is the single biggest source of famotidine drug interactions. If you are taking any medication whose label warns about acid-reducing agents, famotidine is one of the drugs being flagged.

Antifungal Medications

The most well-documented interaction in this category involves itraconazole, an antifungal used for serious infections including aspergillosis and histoplasmosis. In a study where volunteers took itraconazole along with famotidine, the peak blood level of the antifungal dropped by about 53%, and overall drug exposure fell by roughly 51%.¹ That is essentially cutting the drug’s effectiveness in half, which matters enormously when you are treating a potentially life-threatening fungal infection.

Fluconazole, another commonly prescribed antifungal, does not have the same vulnerability. The same study that demonstrated itraconazole’s sensitivity found that fluconazole absorption was not significantly affected by reduced stomach acidity. So the interaction is drug-specific within the antifungal class, not a blanket problem. If you need both an antifungal and an acid reducer, your doctor may switch you to fluconazole or explore timing adjustments, depending on the infection being treated.

Cancer Drugs With pH-Dependent Absorption

Several targeted cancer therapies dissolve poorly in a less acidic stomach, and the consequences can be clinically serious because these drugs often have narrow therapeutic windows. Dasatinib, used in certain leukemias, is one of the worst offenders. Even when famotidine was given a full 10 hours before a dasatinib dose, dasatinib blood levels still dropped by about 60%.² That is a striking result because it means the usual strategy of separating the doses by several hours does not rescue the interaction. For dasatinib, most prescribing guidance simply says to avoid H2 blockers entirely.

Palbociclib, used in advanced breast cancer, shows a similar pattern. A study evaluating the proton pump inhibitor rabeprazole found that acid suppression reduced palbociclib exposure by 62% and peak concentration by 80% under fasted conditions.³ While that specific study tested a proton pump inhibitor rather than famotidine, the underlying problem is the same: any drug that raises stomach pH will reduce palbociclib absorption. Famotidine raises pH less aggressively than proton pump inhibitors, but the direction of the effect is identical.

Nilotinib, another leukemia drug, is a partial exception. A study in healthy volunteers found that famotidine did not significantly reduce nilotinib levels as long as the H2 blocker was taken 10 hours before and 2 hours after the nilotinib dose.⁴ That suggests timing separation can work for nilotinib, unlike dasatinib. But the timing window is strict: deviating from it likely puts drug levels at risk.

HIV Protease Inhibitors

Atazanavir, one of the protease inhibitors used in HIV treatment, needs stomach acid to dissolve. In HIV-positive patients, taking famotidine 40 mg alongside atazanavir boosted with ritonavir reduced atazanavir blood levels by about 20%.⁵ A 20% drop may not sound catastrophic, but with antiretroviral drugs, consistent blood levels are critical for viral suppression and for preventing drug resistance. Even modest dips can push drug concentrations below the threshold needed to keep the virus in check.

HIV treatment guidelines generally allow famotidine with atazanavir under specific conditions: the famotidine dose should not exceed 40 mg twice daily, and timing separation is usually required. But these details vary based on the rest of the patient’s drug regimen, particularly whether tenofovir is also in the mix. This is one of those interactions where the answer is not “never combine them” but rather “only combine them under careful supervision.”

Certain Antibiotics

Not all antibiotics are affected, but some are. Cefpodoxime proxetil, an oral cephalosporin used for respiratory and urinary tract infections, showed reduced absorption when volunteers were pretreated with famotidine 40 mg one hour before taking the antibiotic.⁶ The study measured both peak blood levels and overall drug exposure and found meaningful decreases in both. For a short-course antibiotic, reduced absorption could mean subtherapeutic levels and treatment failure.

Most common antibiotics like amoxicillin, azithromycin, and doxycycline are not pH-dependent in the same way, so this is not a universal problem. But if your pharmacist or prescriber flags the combination, it is worth paying attention. The interaction is easy to miss because cefpodoxime is not prescribed daily the way heartburn medications are taken.

Why Famotidine Rarely Causes Liver-Based Interactions

One of the reasons famotidine is often preferred over the older H2 blocker cimetidine is that it largely stays out of the liver’s drug-processing machinery. Cimetidine binds to cytochrome P450 enzymes, which are responsible for metabolizing a huge range of medications. When cimetidine blocks those enzymes, other drugs build up in the body to potentially dangerous levels. Famotidine shows negligible binding to those same enzymes. Early pharmacology studies confirmed that famotidine had no effect on the metabolism of theophylline, diazepam, phenytoin, warfarin, or antipyrine.⁷ Laboratory work on liver enzymes told the same story: cimetidine markedly affected cytochrome P450 activity, while famotidine only slightly affected it.⁸

This distinction matters practically. If you are on warfarin, theophylline, certain benzodiazepines, or anti-seizure medications and need acid suppression, famotidine is a much safer choice than cimetidine. The interaction profile is not zero, but the liver-enzyme pathway that causes the most dangerous drug accumulations is essentially off the table with famotidine.

Clopidogrel and Blood Thinners

There was a period of genuine alarm about whether acid-reducing drugs interfered with clopidogrel, the antiplatelet medication used after stent placement and heart attacks. The concern centered on proton pump inhibitors like omeprazole, which inhibit CYP2C19, the liver enzyme that converts clopidogrel into its active form. Laboratory testing showed that omeprazole significantly blocked that activation step. Famotidine, by contrast, showed no more than 20% inhibition of clopidogrel activation across the relevant liver enzymes, even at high concentrations.⁹ The researchers concluded that famotidine is a safe acid-suppressing option for patients on clopidogrel.

A clinical study in patients who had undergone coronary stent placement confirmed this. Patients on dual antiplatelet therapy (aspirin plus clopidogrel) who also took famotidine showed no reduction in antiplatelet effect compared to those who took esomeprazole or no acid suppressor at all.¹⁰ For people who need both acid control and clopidogrel, famotidine is often the go-to recommendation specifically because it avoids this interaction.

Mixing Famotidine With Antacids or Other Acid Reducers

Taking famotidine alongside aluminum-magnesium antacids (the chewable or liquid types) reduces how much famotidine gets into your system. The reduction in famotidine absorption is typically around 19-25%.¹¹ Pharmacokinetic reviews have confirmed the same range, noting a 20-30% drop in oral absorption when potent antacids are taken simultaneously.⁷ In practice, this means that if you pop an antacid tablet and take famotidine at the same time, you are partially undermining the famotidine. The simple fix is to separate them by an hour or two.

Combining famotidine with a proton pump inhibitor (like omeprazole or esomeprazole) is a different question. Both suppress acid, but through different mechanisms. Doctors occasionally use them together short-term in hospitalized patients, but for routine outpatient use, doubling up on acid suppressors rarely makes sense and can mask symptoms that warrant investigation. If one acid reducer is not controlling your symptoms, the answer is usually to evaluate why rather than stack a second one on top.

Iron, Vitamin B12, and Long-Term Nutrient Absorption

Your stomach needs acid to liberate iron and vitamin B12 from food. When famotidine reduces acid production, the absorption of these nutrients can decline. A review of the hematological effects of H2 blockers found that while this malabsorption is not clinically important during short-term treatment, long-term use could theoretically contribute to iron or B12 deficiency anemia.¹²

The word “theoretically” is doing real work in that finding. Outright deficiency from famotidine alone is uncommon in people who eat a varied diet. But if you already have borderline iron or B12 status — because of diet, age, heavy menstrual periods, or a vegetarian or vegan eating pattern — long-term famotidine use adds another headwind. Older adults are particularly at risk because B12 absorption naturally declines with age. If you are taking famotidine daily for months or years, periodic blood work to check ferritin and B12 levels is a reasonable precaution.

Calcium absorption also depends somewhat on stomach acid, which is why some guidelines recommend taking calcium citrate rather than calcium carbonate if you are on an acid reducer. Calcium citrate does not require an acidic environment to dissolve.

Metformin and Kidney Transporter Effects

Most famotidine interactions involve stomach pH, but the metformin interaction operates through a completely different pathway. Famotidine inhibits a protein called MATE1, which is involved in pumping metformin out of kidney cells and into the urine. Blocking that transporter could theoretically cause metformin to accumulate, raising the risk of lactic acidosis. However, a clinical study found a result that went in the opposite direction: famotidine actually increased metformin’s renal clearance by about 28%, and the secretory component of that clearance went up by about 36%.¹³

That finding was somewhat surprising and suggests the real-world interaction between famotidine and metformin may be more complex than the laboratory prediction. In practice, the combination is widely used without obvious safety signals, but the interaction is worth knowing about because metformin is one of the most commonly prescribed drugs in the world and famotidine is available over the counter. If you are on metformin and start taking famotidine regularly, mention it to your doctor, particularly if you have any degree of kidney impairment where changes in drug clearance matter more.

Levothyroxine Is Probably Fine

Many people take both a thyroid hormone and an acid reducer, so this question comes up frequently. A study specifically tested whether famotidine affected levothyroxine absorption and found no significant difference. Peak hormone levels and total drug exposure for T4, T3, and free T4 were essentially unchanged after a week of famotidine use.¹⁴ This is a case where the feared interaction simply does not seem to materialize. Proton pump inhibitors have been more controversial on this point, but famotidine appears to get a clean pass for thyroid hormone.

Cardiac Effects in Vulnerable Patients

This is an underappreciated concern. Research using noninvasive heart measurements found that famotidine can exert negative effects on cardiac performance, reducing stroke volume and cardiac output without changing heart rate or blood pressure.¹⁵ A separate study in patients with congestive heart failure compared famotidine to quinidine and found that both drugs produced similar negative effects on heart function.¹⁶

For a healthy person, these effects are unlikely to cause symptoms. But for elderly patients or anyone with heart failure, the reduction in cardiac output could compound problems from other cardiac medications. This is not a drug-drug interaction in the traditional pharmacokinetic sense; it is an additive physiological effect. If you are managing heart failure with drugs that already reduce cardiac workload, adding famotidine to the mix deserves a conversation with your cardiologist.

Famotidine in Kidney Disease

Famotidine is eliminated primarily through the kidneys, so when kidney function declines, the drug sticks around longer. In patients with end-stage renal disease, a study found that most tolerated famotidine at a mean dose of about 24 mg per day, but three out of 38 patients developed mental status changes that were possibly linked to the drug.¹⁷ The symptoms resolved when famotidine was stopped. The implication is straightforward: if your kidneys are significantly impaired, any drug interaction that affects famotidine clearance becomes more consequential. Doses usually need to be cut in half or the dosing interval extended.

This also means that other medications competing for kidney elimination pathways could, in theory, increase famotidine accumulation. While famotidine does not appear to meaningfully compete with the tubular secretion of other common drugs, the reverse is harder to rule out entirely, particularly in patients whose renal function is already compromised.

Practical Timing Strategies

Many famotidine interactions are not absolute contraindications — they are timing problems. A few practical rules cover most situations:

Antifungals like itraconazole: Take with an acidic beverage (like cola) if famotidine cannot be stopped, or switch to fluconazole if the infection type allows it.
Dasatinib: Timing separation does not reliably fix this interaction. Avoid the combination if possible.
Nilotinib: Famotidine can be taken 10 hours before and at least 2 hours after the nilotinib dose.
Atazanavir: Famotidine should be dosed simultaneously with or at least 10 hours apart from the HIV drug, depending on the specific regimen, and should not exceed 40 mg twice daily.
Antacids: Separate by at least one to two hours to avoid reducing famotidine’s own absorption.

For pH-dependent drugs not listed here, the general principle still applies: separate the doses as widely as your schedule allows, and ask your pharmacist whether the specific medication you are taking has a known interaction with acid reducers. Pharmacists often catch these interactions at the dispensing stage, but they cannot flag over-the-counter famotidine purchases you do not mention. If you buy famotidine off the shelf and are on any prescription medication, bring it up at your next appointment or call the pharmacy.